CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Exicure, Inc. (XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) constructs, today announced that its common stock will begin trading on the Nasdaq Capital Market under the symbol “XCUR” at the opening of trading on July 31, 2019, following… Read More..

Riaz Bandali has driven innovation, sales, and profitability in a number of global life science companies Emerald also adds Chief Commercial Officer VICTORIA, British Columbia, July 30, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has appointed Riaz Bandali as Chief Executive Officer. Mr. Bandali has over 25 years… Read More..

SOUTH ORANGE, NJ, July 30, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (NEPH), a commercial-stage company that develops and sells high performance water purification products to the medical device and commercial markets, today announced that it will publish its second quarter 2019 financial results on Wednesday, August 7, 2019… Read More..